Soleno Therapeutics Changes Independent Auditor
Ticker: SLNO · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, administrative
TL;DR
Solen Therapeutics swapped auditors from BDO USA to PwC, effective April 17, 2025.
AI Summary
On April 17, 2025, Soleno Therapeutics, Inc. filed an 8-K report to disclose a change in its certifying accountant. The company has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm, replacing BDO USA, LLP. This change is effective immediately.
Why It Matters
A change in auditor can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, potentially impacting investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine administrative change regarding the company's auditor and does not inherently present new financial or operational risks.
Key Players & Entities
- Soleno Therapeutics, Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — New independent registered public accounting firm
- BDO USA, LLP (company) — Former independent registered public accounting firm
- April 17, 2025 (date) — Effective date of auditor change
FAQ
Why did Soleno Therapeutics, Inc. change its certifying accountant?
The filing states that the change was made by the company and does not indicate any disagreements with BDO USA, LLP.
Who is the new independent registered public accounting firm for Soleno Therapeutics, Inc.?
PricewaterhouseCoopers LLP has been appointed as the new independent registered public accounting firm.
Who was the previous independent registered public accounting firm?
The previous independent registered public accounting firm was BDO USA, LLP.
When was the change in certifying accountant effective?
The change was effective as of April 17, 2025.
Were there any disagreements between Soleno Therapeutics and BDO USA, LLP?
The filing explicitly states that there were no disagreements between Soleno Therapeutics, Inc. and BDO USA, LLP.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).